Results 61 to 70 of about 174,151,826 (255)
Goodness-of-fit test for BTC/EUR.
Goodness-of-fit test for BTC/EUR.
Mario I. Contreras-Valdez (6499304) +2 more
core +1 more source
Cramer-von Mises and Anderson-Darling goodness of fit tests for extreme value distributions with unknown parameters [PDF]
The use of goodness of fit tests based on Cramer-von Mises and Anderson-Darling statistics is discussed, with reference to the composite hypothesis that a sample of observations comes from a distribution, FH, whose parameters are unspecified.
Laio, Francesco, Francesco Laio
core +1 more source
We present robust protocols for the preparation of supported lipid bilayers (SLBs) incorporating either Salmonella smooth LPS or outer membrane vesicles (OMVs). We use a combination of quartz crystal microbalance with dissipation (QCM‐D) and fluorescence microscopy to both characterize the SLBs of various compositions and to probe their interactions ...
Hudson P. Pace +6 more
wiley +1 more source
Goodness-of-fit test for BTC/JPY.
Goodness-of-fit test for BTC/JPY.
Mario I. Contreras-Valdez (6499304) +2 more
core +1 more source
Goodness-of-Fit Test of Shapiro-Wilk Type with Nuisance Regression and Scale
Shapiro and Wilk (1965) proposed a highly intuitive goodness-of-fit test of normality with nuisance location and scale parameters. The test has received a considerable attention in the literature; its asymptotic null distribution is covered by the ...
Pranab Kumar Sen +2 more
doaj +1 more source
Structure‐forward targeting of claudins with synthetic binders
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley +1 more source
Goodness-of-fit test for BTC/RMB.
Goodness-of-fit test for BTC/RMB.
Mario I. Contreras-Valdez (6499304) +2 more
core +1 more source
Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang +2 more
wiley +1 more source

